These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 1624255)

  • 1. The significance of serum lipid-bound sialic acid in bladder tumours.
    Oztokatli A; Ozkardeş H; Ovül E; Erol D
    Int Urol Nephrol; 1992; 24(2):125-9. PubMed ID: 1624255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of serum total lipid and free N-acetylneuraminic acid in genitourinary malignancies by fluorimetric high performance liquid chromatography. Relevance of free N-acetylneuraminic acid as tumour marker.
    Laganà A; Pardo-Martínez B; Marino A; Fago G; Bizzarri M
    Clin Chim Acta; 1995 Dec; 243(2):165-79. PubMed ID: 8747492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The utility of lipid-associated sialic acid (LASA or LSA) as a serum marker for malignancy. A review of the literature.
    Schutter EM; Visser JJ; van Kamp GJ; Mensdorff-Pouilly S; van Dijk W; Hilgers J; Kenemans P
    Tumour Biol; 1992; 13(3):121-32. PubMed ID: 1626178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma lipid bound sialic acid in patients with prostate and bladder cancer.
    Dunzendorfer U; Katopodis N; Dnistrian AM; Stock CC; Schwartz MK; Whitmore WF
    Invest Urol; 1981 Nov; 19(3):194-6. PubMed ID: 7298291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma lipid-bound sialic acid alterations in neoplastic diseases.
    Dwivedi C; Dixit M; Hardy RE
    Experientia; 1990 Jan; 46(1):91-4. PubMed ID: 2298288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Relation between lipid-bound sialic acid in blood serum and plasma andin human tumors].
    Polívková J; Vosmiková K; Pospísil J; Poucková P
    Bratisl Lek Listy; 1992 May; 93(5):222-4. PubMed ID: 1393642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Serum lipid-associated sialic acid (LSA) in diagnosing and monitoring ovarian cancer].
    Yue K; Bian M; Zhu D; Liu W; Siu S
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1995 Apr; 17(2):128-32. PubMed ID: 7656393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Total and lipid-bound serum sialic acid as markers for carcinoma of the uterine cervix.
    Vivas I; Spagnuolo L; Palacios P
    Gynecol Oncol; 1992 Aug; 46(2):157-62. PubMed ID: 1500016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Serum lipid-bound sialic acid as a marker in lung cancer patients].
    Iwahashi N
    Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Dec; 28(12):1599-607. PubMed ID: 2077205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of lipid-bound sialic acid (LSA) as a tumor marker.
    López Sáez JJ; Senra-Varela A
    Int J Biol Markers; 1995; 10(3):174-9. PubMed ID: 8551061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The determination of plasma or serum sialic acid.
    Crook M
    Clin Biochem; 1993 Feb; 26(1):31-8. PubMed ID: 8448836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative study of serum lipid-bound sialic acid and carcinoembryonic antigen in patients with lung cancer].
    Zhu X
    Zhonghua Jie He He Hu Xi Za Zhi; 1990 Feb; 13(1):25-7, 61. PubMed ID: 2165867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of sialic acid and alkaline DNase in breast cancer.
    Raval GN; Parekh LJ; Patel MM; Patel PS; Rawal RM; Balar DB; Patel DD
    Int J Biol Markers; 1997; 12(2):61-7. PubMed ID: 9342634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between lipid-associated sialic acid and tumor burden in melanoma.
    Buzaid AC; Sandler AB; Hayden CL; Scinto J; Poo WJ; Clark MB; Hotchkiss S
    Int J Biol Markers; 1994; 9(4):247-50. PubMed ID: 7836804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A critical analysis of the use of sialic acid determination in the diagnosis of malignancy.
    O'Kennedy R; Berns G; Moran E; Smyth H; Carroll K; Thornes RD; O'Brien A; Fennelly J; Butler M
    Cancer Lett; 1991 Jun; 58(1-2):91-100. PubMed ID: 2049789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Five tumor markers in lung cancer: significance of total and "lipid"-bound sialic acid.
    Kakari S; Stringou E; Toumbis M; Ferderigos AS; Poulaki E; Chondros K; Dema A; Kotsovoulou V; Pavlidis N
    Anticancer Res; 1991; 11(6):2107-10. PubMed ID: 1663720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of serum protein and lipid-bound sialic acid as a marker for genitourinary malignancies.
    Erbil KM; Sen SE; Zincke H; Jones JD
    Cancer; 1986 Apr; 57(7):1389-94. PubMed ID: 3948121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utilization of determining lipid-bound sialic acid for the diagnosis and further prognosis of cancer.
    Polívková J; Vosmiková K; Horák L
    Neoplasma; 1992; 39(4):233-6. PubMed ID: 1436234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B5 tumour marker and urine cytology in diagnosis and follow-up of transitional cell bladder cancer.
    Malpani K; Metcalfe SM; Hinchliffe A
    Br J Urol; 1989 Sep; 64(3):257-62. PubMed ID: 2804562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of CDH13 promoter methylation in serum samples from patients with bladder transitional cell carcinoma.
    Lin YL; Sun G; Liu XQ; Li WP; Ma JG
    J Int Med Res; 2011; 39(1):179-86. PubMed ID: 21672320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.